Pfizer Booster Dose Authorization From US FDA Has Age Caveat: At-Risk Populations 18 And Up

 
• By M. Nielsen Hobbs
  
Pfizer is hoping its booster shot will have a star turn in the pandemic response. • Source: Nielsen Hobbs

More from Vaccines

More from Pink Sheet